ProPhase Labs (PRPH)
(Delayed Data from NSDQ)
$4.50 USD
-0.05 (-1.10%)
Updated Jun 18, 2024 03:59 PM ET
After-Market: $4.50 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, ProPhase Labs (PRPH) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.28 per share. This reflects a positive earnings surprise of 75.00%. Look out for PRPH's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year decrease of 25%.
Earnings History
Price & Consensus
Zacks News for PRPH
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
PRPH: What are Zacks experts saying now?
Zacks Private Portfolio Services